Events & News
2020 Spring I-Corps Life Science Regional Program
Posted January 17, 2020:
The Center for Entrepreneurship Advancement at The University of Texas MD Anderson Cancer Center is excited to open the application portal for our 2020 Spring I-Corps Life Science Regional Program. The program is open to UTHealth teams, and is open to all life science technologies including diagnostics, digital health, medical devices, therapeutics, and more.
Teams will be accepted on a rolling basis, with the first round of interviews beginning February 17th. The final application deadline is March 16th. However, applications may close earlier if all slots are full before March 16th.
Drs. Mukherji, Cooley team up to create Airway Armor™
Posted September 19, 2018: Drs. Mukherji and Cooley from the UTHealth School of Dentistry at Houston have developed the Airway Armor™, a guard that keeps small objects from falling down a patient's throat during dental procedures.
NCATS STTR Funding Opportunities Open for Academic Researchers & Entrepreneurs
Posted May 24, 2018: The National Center for Advancing Translational Sciences (NCATS) at the National Institutes of Health invites researchers at academic institutions to apply for Small Business Technology Transfer (STTR) support to commercialize innovations. The next application deadline is Sept. 5, 2018, 5:00 p.m. local time. STTR programs are one of the largest sources of early-stage technology financing in the U.S.
NCATS is interested in the development of innovative tools, technologies and intervention (drug, device, diagnostic) platforms that would support the creation of novel therapeutics. The NCATS SBIR & STTR research priorities include:
- Drug Discovery & Development
- Biomedical, Clinical & Health Research Informatics
- Clinical, Dissemination & Implementation Research
The STTR program was designed to fund cooperative research and development projects involving a small business and a research institution, i.e., nonprofit college or university, federally funded research and development center, or domestic nonprofit research organization. Program support helps bridge the gap between performance of basic science and commercialization of resulting innovations. Applicants can apply for Phase I or Phase II funding.
Phase I: The objective is to establish the technical merit and feasibility of the proposed research and development efforts and to determine the quality of performance of the small business prior to providing further federal support in Phase II. Phase I support is typically $150,000 provided over a period of six months. However, with proper justification, applicants may propose longer periods of time and greater funding amounts necessary to establish the technical merit and feasibility of the proposed project, up $225,000 in total costs for one year.
Phase II: The objective is to continue the research and development efforts initiated in Phase I. Awards are typically $1 million over two years. With justification and a commercialization plan, applicants may propose funding up to $1.5 million in total costs.
Benefits of Applying:
- Funding is stable, predictable and not a loan
- Capital is non-dilutive
- Small businesses retain intellectual property rights
- NIH’s rigorous peer-review provides recognition, validation and visibility to early-stage companies
- Prestige associated with these awards can help attract more funding or other support (e.g., venture capital, strategic partners)
- Wednesday, May 30 from 3:00 – 4:00 PM EST: Free webinar on SBIR/STTR funding, applicant support programs, and local resources by NCATS, NCI and the Women’s Business Development Center. Register now!
- June 4 – 7, BIO International 2018 in Boston: NCATS will be at BIO this year! Contact us to set up a one-to-one meeting to discuss STTR funding opportunities and resources with Lili Portilla, Director of Strategic Alliances at NCATS.
TMCx Open 2018 Medical Device Cohort Application
Deadline: May 14, 2018
TMCx lowers barriers of access to the world's largest medical center, allowing startups to leverage our expansive network of advisors from the 21 Texas Medical Center hospitals and our tailored curriculum to clinically validate and find product-market fit for their solutions.
The TMCx Medical Device 2017 cohort of 19 startups raised $26M and had over 43 engagements with potentials customers in the form of pilots and agreements over the course of our three-month program.